Days at Home After Traumatic Brain Injury: Moving Beyond Mortality to Evaluate Patient-Centered Outcomes Using Population Health Data.

IF 7.7 1区 医学 Q1 CLINICAL NEUROLOGY
Neurology Pub Date : 2024-10-22 Epub Date: 2024-09-16 DOI:10.1212/WNL.0000000000209904
Armaan K Malhotra, Avery B Nathens, Husain Shakil, Rachael H Jaffe, Ahmad Essa, Francois Mathieu, Jetan H Badhiwala, Eva Y Yuan, Kevin Thorpe, Abhaya V Kulkarni, Christopher D Witiw, Jefferson R Wilson
{"title":"Days at Home After Traumatic Brain Injury: Moving Beyond Mortality to Evaluate Patient-Centered Outcomes Using Population Health Data.","authors":"Armaan K Malhotra, Avery B Nathens, Husain Shakil, Rachael H Jaffe, Ahmad Essa, Francois Mathieu, Jetan H Badhiwala, Eva Y Yuan, Kevin Thorpe, Abhaya V Kulkarni, Christopher D Witiw, Jefferson R Wilson","doi":"10.1212/WNL.0000000000209904","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Administrative data are invaluable for assessing outcomes at the population level. However, there are few validated patient-centered outcome measures that capture morbidity following traumatic brain injury (TBI) using these data. We sought to characterize and validate days at home (DAH) as a measure to quantify population-level outcomes after moderate to severe TBI. We additionally assessed the earliest feasible outcome assessment period for patients with TBI using this outcome measure.</p><p><strong>Methods: </strong>This multicenter retrospective cohort study used linked health administrative data sources to identify adults with moderate to severe TBI presenting to trauma centers in Ontario, Canada, between 2009 and 2021. DAH at 180 days (DAH<sub>180 days</sub>) reflects the total number of days spent alive and at home excluding the days spent institutionalized across care settings. Construct validity was determined using hierarchical quantile regression to assess the associations between clinical and injury covariates with DAH<sub>180 days</sub>. Predictive validity was assessed using Spearman rank correlation. We estimated minimally important difference (MID) in DAH<sub>180 days</sub> to aid with outcome measure interpretability.</p><p><strong>Results: </strong>There were 6,340 patients who met inclusion criteria. Median DAH<sub>180 days</sub> was 70 days (interquartile range 0-144). Mortality occurred in 2,162 (34.1%) patients within 90 days following injury. Patients in the lower DAH<sub>180 days</sub> group were more commonly older (absolute standardized difference [ASD] = 0.68) with higher preinjury health resource utilization (ASD = 0.36) and greater injury severity (ASD = 0.81). Increased baseline health resource utilization (-10.1 days, 95% CI -17.4 to -2.8, <i>p</i> = 0.0041), older age (-4.6 days, 95% CI -5.7 to -3.4, <i>p</i> < 0.001), higher cranial injury severity (-84.6 days, 95% CI -98.3 to -71.0, <i>p</i> < 0.001), and major extracranial injuries (-14.2 days, 95% CI -19.5 to -8.93, <i>p</i> < 0.001) were significantly associated with fewer DAH<sub>180 days</sub>. DAH<sub>180 days</sub> was positively correlated with DAH at up to 3 years (<i>r</i> = 0.91, 95% CI 0.90-0.92) and negatively correlated with direct health care expenditure (<i>r</i><sub>s</sub> = -0.89, 95% CI -0.88 to -0.90). The average MID estimated from anchor-based and distribution-based methods was 18 days.</p><p><strong>Discussion: </strong>We validate DAH<sub>180 days</sub> as a potentially useful outcome measure with construct, predictive, and face validity in a population with moderate to severe TBI. Given the intensity of acute care requirements for patients with TBI, our work highlights DAH<sub>180 days</sub> as a feasible and sufficiently responsive outcome measure.</p>","PeriodicalId":19256,"journal":{"name":"Neurology","volume":null,"pages":null},"PeriodicalIF":7.7000,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1212/WNL.0000000000209904","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/16 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objectives: Administrative data are invaluable for assessing outcomes at the population level. However, there are few validated patient-centered outcome measures that capture morbidity following traumatic brain injury (TBI) using these data. We sought to characterize and validate days at home (DAH) as a measure to quantify population-level outcomes after moderate to severe TBI. We additionally assessed the earliest feasible outcome assessment period for patients with TBI using this outcome measure.

Methods: This multicenter retrospective cohort study used linked health administrative data sources to identify adults with moderate to severe TBI presenting to trauma centers in Ontario, Canada, between 2009 and 2021. DAH at 180 days (DAH180 days) reflects the total number of days spent alive and at home excluding the days spent institutionalized across care settings. Construct validity was determined using hierarchical quantile regression to assess the associations between clinical and injury covariates with DAH180 days. Predictive validity was assessed using Spearman rank correlation. We estimated minimally important difference (MID) in DAH180 days to aid with outcome measure interpretability.

Results: There were 6,340 patients who met inclusion criteria. Median DAH180 days was 70 days (interquartile range 0-144). Mortality occurred in 2,162 (34.1%) patients within 90 days following injury. Patients in the lower DAH180 days group were more commonly older (absolute standardized difference [ASD] = 0.68) with higher preinjury health resource utilization (ASD = 0.36) and greater injury severity (ASD = 0.81). Increased baseline health resource utilization (-10.1 days, 95% CI -17.4 to -2.8, p = 0.0041), older age (-4.6 days, 95% CI -5.7 to -3.4, p < 0.001), higher cranial injury severity (-84.6 days, 95% CI -98.3 to -71.0, p < 0.001), and major extracranial injuries (-14.2 days, 95% CI -19.5 to -8.93, p < 0.001) were significantly associated with fewer DAH180 days. DAH180 days was positively correlated with DAH at up to 3 years (r = 0.91, 95% CI 0.90-0.92) and negatively correlated with direct health care expenditure (rs = -0.89, 95% CI -0.88 to -0.90). The average MID estimated from anchor-based and distribution-based methods was 18 days.

Discussion: We validate DAH180 days as a potentially useful outcome measure with construct, predictive, and face validity in a population with moderate to severe TBI. Given the intensity of acute care requirements for patients with TBI, our work highlights DAH180 days as a feasible and sufficiently responsive outcome measure.

创伤性脑损伤后在家的日子:超越死亡率,利用人口健康数据评估以患者为中心的结果。
背景和目标:管理数据对于评估人口层面的结果非常宝贵。然而,很少有经过验证的以患者为中心的结果测量方法,可以利用这些数据来捕捉创伤性脑损伤(TBI)后的发病率。我们试图描述并验证居家天数(DAH),将其作为量化中度至重度创伤性脑损伤后人群水平结果的一项指标。此外,我们还利用这一结果指标评估了创伤性脑损伤患者最早可行的结果评估期:这项多中心回顾性队列研究使用了相关的健康管理数据源,以识别 2009 年至 2021 年期间在加拿大安大略省创伤中心就诊的中重度创伤性脑损伤成人患者。180天的DAH(DAH180天)反映了患者在家中存活的总天数,但不包括在不同护理环境中住院的天数。采用分层量化回归评估临床和损伤协变量与 DAH180 天之间的关系,从而确定结构有效性。预测有效性采用斯皮尔曼等级相关性进行评估。我们估算了DAH180天的最小重要差异(MID),以帮助结果测量的可解释性:共有 6340 名患者符合纳入标准。DAH180天的中位数为70天(四分位距为0-144)。有 2162 名患者(34.1%)在受伤后 90 天内死亡。DAH180天数较低组的患者通常年龄较大(绝对标准化差异[ASD] = 0.68),受伤前医疗资源利用率较高(ASD = 0.36),受伤严重程度较高(ASD = 0.81)。基线医疗资源利用率增加(-10.1 天,95% CI -17.4 至 -2.8,p = 0.0041)、年龄增大(-4.6 天,95% CI -5.7 至 -3.4,p < 0.001)、颅脑损伤严重程度增高(-84.6天,95% CI -98.3 to -71.0,p < 0.001)和主要颅外损伤(-14.2天,95% CI -19.5 to -8.93,p < 0.001)与较少的DAH180天显著相关。DAH180天数与长达3年的DAH呈正相关(r = 0.91,95% CI 0.90-0.92),与直接医疗支出呈负相关(rs = -0.89,95% CI -0.88--0.90)。讨论:我们验证了 DAH180 天是一个潜在有用的结果测量指标,在中重度创伤性脑损伤人群中具有构造、预测和表面效度。考虑到创伤性脑损伤患者对急性护理的需求强度,我们的工作强调了DAH180天是一个可行且反应充分的结果测量指标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neurology
Neurology 医学-临床神经学
CiteScore
12.20
自引率
4.00%
发文量
1973
审稿时长
2-3 weeks
期刊介绍: Neurology, the official journal of the American Academy of Neurology, aspires to be the premier peer-reviewed journal for clinical neurology research. Its mission is to publish exceptional peer-reviewed original research articles, editorials, and reviews to improve patient care, education, clinical research, and professionalism in neurology. As the leading clinical neurology journal worldwide, Neurology targets physicians specializing in nervous system diseases and conditions. It aims to advance the field by presenting new basic and clinical research that influences neurological practice. The journal is a leading source of cutting-edge, peer-reviewed information for the neurology community worldwide. Editorial content includes Research, Clinical/Scientific Notes, Views, Historical Neurology, NeuroImages, Humanities, Letters, and position papers from the American Academy of Neurology. The online version is considered the definitive version, encompassing all available content. Neurology is indexed in prestigious databases such as MEDLINE/PubMed, Embase, Scopus, Biological Abstracts®, PsycINFO®, Current Contents®, Web of Science®, CrossRef, and Google Scholar.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信